We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£490.00
It has never been this cheap. We have no record of a lower price.
£490 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Chronic Myelogenous Leukemia Treatments for US Zip Codes
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 32 days · 32 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 32 days • 1 price levels
Price Analysis
Most common price: £490 (32 days, 100.0%)
Price range: £490 - £490
Price levels: 1 different prices over 32 days
Description
This study covers the latent demand outlook for chronic myelogenous leukemia treatments across the states and zip codes of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 10,833 zip codes in the United States. For each zip code in question, the percent share the zip code is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a zip code vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and zip code, latent demand estimates are created for chronic myelogenous leukemia treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of chronic myelogenous leukemia treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Bio-Path Holdings, Bristol Myers Squibb, F. Hoffmann-La Roche, Hoffman-LaRoche, Incyte, Novartis, Pfizer, Schering Plough, and Teva Pharmaceutical Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BSJLN9QP
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 09 January 2023
- Listed Since
- 26 January 2023
Similar Products You Might Like
97% match
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
£495.00
14 Aug 2026
97% match
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
£495.00
22 Aug 2026
97% match
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
£325.00
03 Sep 2026
97% match
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
£495.00
20 Aug 2026
97% match
Myeloid Leukemia: Clinical Diagnosis and Treatment Guide
IntechOpen
£129.16
09 Oct 2026
96% match
Myeloid Leukemia: Methods and Protocols - Medical Research Guide
Humana
£103.66
20 Oct 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Europe
£425.00
20 Aug 2026
96% match
Chronic Myeloid Leukemia (Hematologic Malignancies)
Springer
£81.74
11 Sep 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in North America & the Caribbean
£425.00
20 Aug 2026
96% match
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
Price unavailable
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Asia
£425.00
20 Aug 2026
96% match
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments for US Zip Codes
£490.00
28 Aug 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in the Middle East
£425.00
21 Aug 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Africa
£425.00
21 Aug 2026
96% match
The 2023-2028 World Outlook for Hematologic Malignancies
Price unavailable
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
£595.00
01 Oct 2026
96% match
The 2021-2026 World Outlook for Hematology and Oncology Products
£795.00
20 Aug 2026
96% match
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America (Volume 39-5) (The Clinics: Internal Medicine, Volume 39-5)
Elsevier
£75.36
23 Sep 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Oceana
£425.00
21 Aug 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
£595.00
18 Sep 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in India
£595.00
22 Aug 2026
96% match
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
£495.00
22 Aug 2026
96% match
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
£490.00
28 Aug 2026
96% match
The 2016-2021 Outlook for Hematology and Oncology Products in Japan
£595.00
21 Aug 2026